Company intelligence / Profile preview

Ultraviolet Interventions

Baltimore, Maryland, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Ultraviolet Interventions is developing a proprietary ultraviolet fiber optic platform designed to treat and prevent infections associated with catheters. The company is focused on leveraging UV light delivered via fiber optics to sterilize the internal surfaces of catheters, aiming to reduce infection rates in patients requiring vascular access devices. There are no published results from advanced clinical trials as of now.

Therapeutic areas: Infectious Diseases
Modalities: DeviceFiber optic-based therapy (specifically ultraviolet fiber optics)
Industry: Therapeutic Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Ultraviolet Interventions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultraviolet Interventions.

Explore the full profile